Literature DB >> 14690317

Pelvic exenteration and reconstruction.

Emery M Salom1, Manuel A Penalver.   

Abstract

For the past six decades, pelvic extenteration has been utilized in the treatment of localized central pelvic recurrences after chemo/radiotherapy. The radicality of the procedure that includes resection of the bladder, vulva/vagina, and rectum, although with curative intent, results in comprehensive changes for the patient. For this reason, all patients should undergo extensive psychosocial counseling to prepare them for the changes in body image and lifestyle. Extirpation of the pelvic viscera has undergone a number of modifications since Brunschwig first described it in 1948 to maximize survivability and minimized anatomical distortion. Most of the advancements have been focused on the reconstructive phase after pelvic exenteration. A few select patients can be free of any external appliances such as a colostomy bag with utilization of a low colorectal anastomosis, and can maintain sexual intimacy with creation of a neovagina. In addition, reconstruction of the pelvic floor with omental flaps, dura mater grafts and myocutaneous flaps have decreased postoperative morbidity. In this article, we provide a review of pelvic exenteration in gynecologic oncology, emphasizing preoperative evaluation, surgical techniques and their postoperative management.

Entities:  

Mesh:

Year:  2003        PMID: 14690317     DOI: 10.1097/00130404-200309000-00012

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  7 in total

1.  Vulva reconstruction after pelvic exenteration, using a unique combination of two flaps.

Authors:  Annelotte C M van Bommel; Henk W R Schreuder; Pascal P A Schellekens
Journal:  BMJ Case Rep       Date:  2011-06-17

2.  Pelvic exenteration for recurrent or persistent cervical cancer: experience of five years at the National Cancer Institute in Mexico.

Authors:  M A Terán-Porcayo; I Zeichner-Gancz; R A C Gomez del-Castillo; A Beltrán-Ortega; G Solorza-Luna
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

Review 3.  Role of MR Imaging and FDG PET/CT in Selection and Follow-up of Patients Treated with Pelvic Exenteration for Gynecologic Malignancies.

Authors:  Yulia Lakhman; Stephanie Nougaret; Maura Miccò; Chiara Scelzo; Hebert A Vargas; Ramon E Sosa; Elizabeth J Sutton; Dennis S Chi; Hedvig Hricak; Evis Sala
Journal:  Radiographics       Date:  2015 Jul-Aug       Impact factor: 5.333

4.  Pelvic reconstruction with allogeneic bone graft after tumor resection.

Authors:  Wei Wang; Wen Zhi Bi; Jing Yang; Gang Han; Jin Peng Jia
Journal:  Acta Ortop Bras       Date:  2013-05       Impact factor: 0.513

5.  Total pelvic exenteration for gynecologic malignancies.

Authors:  Elisabeth J Diver; J Alejandro Rauh-Hain; Marcela G Del Carmen
Journal:  Int J Surg Oncol       Date:  2012-06-10

6.  Pelvic exenteration case series: A single surgeon's experience at one institution in Trinidad and Tobago.

Authors:  Ravi Maharaj; Vandana Devika Sookdeo; Maurice Fortuné; Meenakshi Akhilesh; Chalapathi Rao Adidam Venkata; Wayne Mohammed; Dave Harnanan; Wayne A Warner
Journal:  Int J Surg Case Rep       Date:  2017-03-07

7.  Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea.

Authors:  Heon Jong Yoo; Myong Cheol Lim; Sang-Soo Seo; Sokbom Kang; Chong Woo Yoo; Joo-Young Kim; Sang-Yoon Park
Journal:  J Gynecol Oncol       Date:  2012-09-19       Impact factor: 4.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.